Total Valuation
Hana Pharm Co., Ltd. has a market cap or net worth of ₩144.10B. The enterprise value is ―.
Market Cap₩144.10B
Enterprise Value―
Share Statistics
Hana Pharm Co., Ltd. has 17,772,945 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,772,945
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hana Pharm Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.20%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.20%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee328.09M
Profits Per Employee12.02M
Employee Count730
Asset Turnover0.57
Inventory Turnover1.60
Valuation Ratios
The current PE Ratio of Hana Pharm Co., Ltd. is 10.1. Hana Pharm Co., Ltd.’s PEG ratio is -0.38.
PE Ratio10.1
PS Ratio0.83
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-10.04
Price to Operating Cash Flow15.11
PEG Ratio-0.38
Income Statement
In the last 12 months, Hana Pharm Co., Ltd. had revenue of 239.50B and earned 8.78B in profits. Earnings per share was 507.00.
Revenue239.50B
Gross Profit146.39B
Operating Income25.92B
Pretax Income18.38B
Net Income8.78B
EBITDA36.95B
Earnings Per Share (EPS)507.00
Cash Flow
In the last 12 months, operating cash flow was 9.75B and capital expenditures -62.78B, giving a free cash flow of -53.03B billion.
Operating Cash Flow9.75B
Free Cash Flow-53.03B
Free Cash Flow per Share-2.98K
Dividends & Yields
Hana Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.12
52-Week Price Change-28.93%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)29.63K
Important Dates
Hana Pharm Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Hana Pharm Co., Ltd. as a current ratio of 1.84, with Debt / Equity ratio of 20.68%
Current Ratio1.84
Quick Ratio0.93
Debt to Market Cap0.28
Net Debt to EBITDA1.32
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hana Pharm Co., Ltd. has paid 9.55B in taxes.
Income Tax9.55B
Effective Tax Rate0.52
Enterprise Valuation
Hana Pharm Co., Ltd. EV to EBITDA ratio is 6.72, with an EV/FCF ratio of -12.50.
EV to Sales1.04
EV to EBITDA6.72
EV to Free Cash Flow-12.50
EV to Operating Cash Flow27.06
Balance Sheet
Hana Pharm Co., Ltd. has ₩6.57B in cash and marketable securities with ₩66.07B in debt, giving a net cash position of -₩59.50B billion.
Cash & Marketable Securities₩6.57B
Total Debt₩66.07B
Net Cash-₩59.50B
Net Cash Per Share-₩3.35K
Tangible Book Value Per Share₩16.62K
Margins
Gross margin is 61.62%, with operating margin of 10.82%, and net profit margin of 3.67%.
Gross Margin61.62%
Operating Margin10.82%
Pretax Margin7.67%
Net Profit Margin3.67%
EBITDA Margin15.43%
EBIT Margin10.82%
Analyst Forecast
The average price target for Hana Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.21%
EPS Growth Forecast-26.25%